NYSE:AZN - AstraZeneca Price Target & Analyst Ratings

$40.11
-0.62 (-1.52 %)
(As of 07/19/2019 04:00 PM ET)
Today's Range
$40.06
Now: $40.11
$40.62
50-Day Range
$37.38
MA: $40.19
$41.99
52-Week Range
$35.30
Now: $40.11
$43.29
Volume235,427 shs
Average Volume2.06 million shs
Market Capitalization$101.59 billion
P/E Ratio11.60
Dividend Yield4.61%
Beta0.53

Analyst Ratings

AstraZeneca (NYSE:AZN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
17 Wall Street analysts have issued ratings and price targets for AstraZeneca in the last 12 months. Their average twelve-month price target is $45.3460, suggesting that the stock has a possible upside of 13.05%. The high price target for AZN is $48.00 and the low price target for AZN is $40.73. There are currently 3 sell ratings, 3 hold ratings and 11 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.472.472.472.40
Ratings Breakdown: 3 Sell Rating(s)
3 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
3 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
3 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
5 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $45.3460$45.3460$45.3460$43.60
Price Target Upside: 13.05% upside19.36% upside9.88% upside20.74% upside

AstraZeneca (NYSE:AZN) Consensus Price Target History

AstraZeneca (NYSE:AZN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/29/2019Pareto SecuritiesUpgradeSell ➝ HoldLowView Rating Details
4/2/2019UBS GroupDowngradeNeutral ➝ Sell$40.73MediumView Rating Details
4/1/2019CowenUpgradeMarket Perform ➝ Outperform$42.00 ➝ $48.00LowView Rating Details
3/19/2019Main First BankReiterated RatingBuyLowView Rating Details
2/28/2019HSBCReiterated RatingSellMediumView Rating Details
2/26/2019Deutsche BankReiterated RatingBuyLowView Rating Details
2/26/2019Goldman Sachs GroupReiterated RatingSellLowView Rating Details
2/5/2019Exane BNP ParibasInitiated CoverageOutperformLowView Rating Details
1/15/2019BMO Capital MarketsReiterated RatingBuy$48.00MediumView Rating Details
12/14/2018Bank of AmericaReiterated RatingBuyLowView Rating Details
12/13/2018SunTrust BanksInitiated CoverageBuy$48.00LowView Rating Details
12/11/2018Jefferies Financial GroupReiterated RatingHold ➝ Hold$42.00MediumView Rating Details
12/9/2018Credit Suisse GroupReiterated RatingBuyLowView Rating Details
11/19/2018InvestecDowngradeBuy ➝ HoldMediumView Rating Details
10/23/2018Wolfe ResearchInitiated CoverageOutperformLowView Rating Details
10/8/2018GuggenheimInitiated CoverageBuy ➝ BuyLowView Rating Details
6/12/2018MorningstarReiterated RatingHoldLowView Rating Details
2/6/2018Leerink SwannBoost Price TargetMarket Perform ➝ Market Perform$36.00 ➝ $38.00MediumView Rating Details
2/5/2018Sanford C. BernsteinBoost Price TargetOutperform$40.00 ➝ $42.00HighView Rating Details
12/29/2017JPMorgan Chase & Co.UpgradeNeutral ➝ OverweightLowView Rating Details
10/18/2017CitigroupUpgradeBuyN/AView Rating Details
9/14/2017Liberum CapitalDowngradeBuy ➝ HoldLowView Rating Details
9/6/2017NatixisUpgradeNeutral ➝ BuyLowView Rating Details
9/1/2017ArgusReiterated RatingBuy$35.00LowView Rating Details
8/9/2017Piper Jaffray CompaniesReiterated RatingBuyLowView Rating Details
7/28/2017Morgan StanleyDowngradeOverweight ➝ Equal WeightHighView Rating Details
(Data available from 7/19/2017 forward)
This page was last updated on 7/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel